UNSPSC 51442003: Fluorodopa

This classification denotes a radio tracer used in PET analysis, with a molecular formula of C9H10FNO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2C598205QX. The European Medicines Agency schedules Fluorodopa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07719MIG. Most nations schedule Fluorodopa under HS 28444030. SMILES: C1=C(C(=CC(=C1O)O)F)CC(C(=O)O)N.

UNSPSC 51442003 Fluorodopa, a Commodity code, nominally designates a specific radiopharmaceutical compound used in positron emission tomography (PET) imaging. However, recent state and local solicitations tagged with this code show little alignment with the code's intended scope. The four recent opportunities posted between June and October 2026 involve radiologic equipment procurement and installation, X-ray machine extended warranties, X-ray inspection system maintenance services, and copper sulfate chemicals — none of which constitute fluorodopa or radiopharmaceuticals. The mismatch suggests either tagging errors by the issuing bodies or a systematic misalignment between the code definition and how procurement offices are applying it in practice. State and local governments do purchase medical imaging equipment, diagnostic services, and maintenance contracts, but these opportunities are not correctly classified under a pharmaceutical radioisotope code.

The geographic spread of tagged activity spans Florida (Escambia County Correction, Broward County Aviation Department, and Pasco County) and Arizona (Maricopa County), with no concentrated pattern. Issuing bodies include county departments and government authorities. Representative recent solicitations include Maricopa County's IFB 362910 (radiologic equipment and installation for three colleges, due October 22, 2026); Escambia County Correction's sole-source IFB for extended warranty coverage on X-ray machines (due August 19, 2026); and Broward County Aviation Department's RFI posted June 25, 2026 (due July 28, 2026) for maintenance services on Rapiscan X-ray inspection systems. Given the absence of genuine fluorodopa or radiopharmaceutical procurement signals, firms pursuing work in medical imaging, diagnostic equipment, or related services should verify code alignment directly with issuing bodies rather than relying on this code classification.